menu ☰
menu ˟

Bevacizumab (Avastin) or Ranibizumab (Lucentis) for a 64 year old with chronic macular oedema secondary to central retinal vein obstruction

Creator:

Islington PCT

Subject Keywords: Ranibizumab, Bevacizumab, lucentis, Avastin, individual treatments, Exceptional treatments, Clinical exceptions
Type: Report
Region: United Kingdom
Description:

refer to the resource

Date:

05/05/2009

Rights: refer to the resource
Suggested citation:

Islington PCT. (2009) Bevacizumab (Avastin) or Ranibizumab (Lucentis) for a 64 year old with chronic macular oedema secondary to central retinal vein obstruction [Online]. Available from: http://publichealthwell.ie/node/26539 [Accessed: 17th November 2019].

  

View your saved citations and reading lists

Contributor:

APHO
 
Click here to view all the resources gathered from this organisation's website.